The buyback program is effective immediately and will run through Dec. 31, 2026. It reflects the company’s confidence in its financial health and aims to enhance shareholder value. Earlier, Regional ...
Predictive Oncology does not intend to discuss or disclose further developments regarding the exploration of strategic alternatives unless and until its Board of Directors has approved a specific ...